Aesthetic plastic surgery
Aesthetic plastic surgery
Audio Summaries
Every issue of Aesthetic plastic surgery moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Aesthetic plastic surgery.
Complications of Oncoplastic Mammoplasty in Cancer-Affected Versus Healthy Contralateral Breasts: A Retrospective Cohort Analysis.
Nov 19, 2026
This retrospective cohort of 229 breast cancer patients compared postoperative complications between tumor-bearing breasts (oncoplastic breast-conserving surgery) and healthy contralateral breasts (reduction mammoplasty for symmetry) within the same patients. The authors asked whether the cancer-affected breast has higher surgical morbidity and whether oncoplastic surgery remains oncologically safe. Complications were significantly more frequent on the tumor-bearing side (8% vs. 0.44% complication-free difference, P < 0.001), with all major complications occurring there, yet the 97.38% negative margin rate and 0.87% local recurrence rate suggest oncoplastic mammoplasty is a feasible and safe option.
Online Patient Education Materials on Breast Implant Illness: A Readability, Quality, and Content Analysis.
Nov 18, 2026
This study evaluated the readability, quality, and content coverage of the top 50 English-language online patient education materials on breast implant illness (BII), a cluster of systemic symptoms some patients attribute to breast implants. The authors asked whether these materials are accessible, reliable, and comprehensive enough to support informed decisions about implant or capsule removal. They found that all materials were written well above recommended reading levels, showed low reliability and actionability, and incompletely covered key BII-specific topics, with no meaningful differences across surgeon-advertiser, non-advertising surgeon, and institutional publishers.
Impact of Implant Surface Texture on Complication Rates in Primary Breast Augmentation: A Systematic Review and Meta-analysis.
Nov 18, 2026
This systematic review and meta-analysis of 12 studies (17,726 patients) asked whether implant surface texture (smooth vs. textured) affects complication rates in primary breast augmentation. Textured implants were associated with a significantly lower risk of bottoming-out deformity, while capsular contracture, infection, seroma, and reoperation rates did not differ significantly, and no BIA-ALCL cases were detected. The authors conclude that implant selection should be individualized, balancing mechanical advantages, regulatory considerations, availability, and patient preference.
Plication-Induced Pseudotumor and Umbilical Pseudohernia (PIP-UP) After Abdominoplasty: Pathophysiology, Clinical Presentation, and Surgical Management.
Nov 17, 2026
This retrospective series of 26 patients examines plication-induced pseudotumor and umbilical pseudohernia (PIP-UP), a deformity where soft tissue becomes entrapped within the vertical rectus plication line after abdominoplasty. The authors asked whether this condition can be recognized and surgically corrected, and they report complete resolution in all patients using excision of entrapped tissue, neoumbilicoplasty, scar repositioning, and selective transverse plication. Umbilical appearance scores and scar-umbilicus proportionality (H/V ratio) improved significantly, supporting PIP-UP as a correctable postoperative sequela.
An Updated Meta-analysis of the Metabolic Health Trajectory Following Liposuction: From Immediate Changes to Sustained Effects.
Nov 17, 2026
This meta-analysis of 32 studies (1,371 participants) asks how metabolic markers change after liposuction, from early postoperative periods to long-term follow-up. The authors found that body weight, BMI, total cholesterol, LDL, and insulin resistance improved significantly in the long term (≥6 months), while other parameters changed on different timelines. They conclude that the post-liposuction metabolic trajectory is parameter-specific and temporally heterogeneous, with evidence certainty ranging from moderate to high.
Subconjunctival Injection of Hyaluronic Acid Versus Triamcinolone Acetonide in Thyroid Eye Disease-related Upper Eyelid Retraction: A Pilot Study.
Nov 17, 2026
This pilot study asked whether a single subconjunctival injection of hyaluronic acid (Restylane Eyelight) or triamcinolone acetonide can objectively improve upper eyelid retraction in patients with thyroid eye disease, measured by MRD1 on standardized photographs over six months. In 16 eyes from 13 patients (11 receiving triamcinolone, 5 receiving hyaluronic acid), both treatments produced a significant reduction in MRD1 of about 1.0 mm at six months, with no significant difference between agents and high, comparable satisfaction. Only mild transient edema and small depot formation were observed, suggesting both may be safe, minimally invasive options for mild-to-moderate cases, though the small, unbalanced sample limits firm conclusions.
The Next Step in Facial Aesthetic Surgery Outcome Evaluation: Quantifying Classical Deep Plane versus Preservation Facelift with 3-Dimensional Surface Imaging.
Nov 16, 2026
This retrospective study of 32 female facelift patients compared soft tissue displacement between the preservation facelift (PFL, n=18) and classical deep plane facelift (DP, n=14) using 3D surface imaging at 6 months. The authors asked whether the PFL produces greater vectorial soft tissue movement than the DP, and found that PFL showed significantly greater displacement across most facial regions and axes. Because technique allocation was non-randomized and the sample was small, the authors caution that larger, long-term studies are needed to confirm durability and clinical benefit.
Balancing Function and Aesthetics: Clinical Insights from Contemporary Rhinoplasty in a Regional Middle Eastern Cohort.
Nov 16, 2026
This retrospective study reviewed 263 primary rhinoplasty cases performed by a single surgeon in a mixed private and university setting in the Middle East (April 2023 to April 2025) to characterize patient priorities, surgical planning, and short-term outcomes. Patient-reported satisfaction, measured with the Arabic ROE questionnaire, improved substantially from 31.45 to 84.79 postoperatively, with greater satisfaction linked to female gender, open approach, and cartilaginous grafts, and no major complications or revisions reported. The authors conclude that the case mix and outcomes offer practical guidance for facial plastic surgeons treating similar regional populations.
Prophylactic Intralesional Botulinum Toxin Type A Versus Triamcinolone Acetonide Followed by Combination Therapy for Keloid Prevention and Treatment in High-Risk Orthopedic Surgery Patients: A Retrospective Comparative Study.
Nov 16, 2026
This retrospective study compared prophylactic intralesional botulinum toxin type A (BTX-A) with triamcinolone acetonide (TAC) in 74 keloid-prone patients undergoing orthopedic surgery, and assessed combined BTX-A+TAC therapy for those who developed keloids. Keloid formation rates were similar between groups, but BTX-A was associated with a longer time to formation and smaller lesion diameter, while TAC-prophylaxed patients responded better to subsequent combination therapy. The authors conclude that combined BTX-A+TAC is well tolerated and potentially effective for managing keloids in high-risk surgical patients, though the non-randomized design limits causal conclusions.
Efficacy and Safety of a Polycaprolactone-Based Injectable Filler for the Correction of Mild-to-Moderate Chin Retrusion in Adults Compared with No Treatment: A Multicenter, Randomized Controlled Study.
Nov 15, 2026
This multicenter randomized controlled trial asked whether a polycaprolactone (PCL)-based injectable filler could effectively and safely correct mild-to-moderate chin retrusion compared with no treatment. In 162 adults randomized 2:1, 93.33% of treated subjects were GCRS responders at Week 24 versus 0% of controls, with improvements maintained descriptively through Week 60. Injection-site reactions were common (85.71%) but mostly mild and transient, and no serious device-related adverse events occurred; the authors note the study cannot establish superiority over active comparators.
